Gubra A/S Logo

Gubra A/S

Preclinical CRO and peptide drug developer for metabolic and fibrotic diseases.

GUBRA | CO

Overview

Corporate Details

ISIN(s):
DK0062266474
LEI:
254900T17RRFZONO6W53
Country:
Denmark
Address:
Hørsholm Kongevej 11 B, 2970 Hørsholm
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

Gubra is a biotechnology company and preclinical Contract Research Organization (CRO) founded in 2008. The company operates a dual business model, providing specialized preclinical research services while simultaneously developing its own pipeline of peptide-based therapeutics. Gubra's core expertise lies in metabolic diseases (such as obesity, diabetes, and MASH) and fibrotic diseases. Its CRO services support pharmaceutical and biotech clients with advanced studies, including in vivo pharmacology and peptide chemistry. The drug discovery division focuses on advancing a proprietary portfolio of novel drug candidates, with research and development efforts also extending into inflammatory, CNS, respiratory, and women's health conditions. This integrated approach combines stable service revenue with the long-term potential of therapeutic innovation.

Social Media

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Gubra A/S and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Gubra A/S filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Gubra A/S via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
FARON PHARMACEUTICALS OY Logo
Develops myeloid cell-targeting immunotherapies for solid and hematological cancers.
Finland FARN
Fluicell AB Logo
Developing bioprinted tissues for regenerative medicine and advanced drug screening.
Sweden FLUI
FluoGuide A/S Logo
Develops fluorescent drugs to guide surgeons for more precise cancer removal and patient outcomes.
Denmark FLUO
FUSION ANTIBODIES PLC Logo
A CRO providing end-to-end antibody engineering services for therapeutic & diagnostic development.
United Kingdom FAB
FUTURA MEDICAL PLC Logo
Develops topical sexual health gels, including a fast-acting, over-the-counter ED treatment.
United Kingdom FUM
Gabather AB Logo
Clinical-stage pharma developing GABAA therapeutics for neuropsychiatric disorders.
Sweden GABA
GEIGER COUNTER LIMITED Logo Jersey GCL
Geneuro Logo
Develops HERV-targeting treatments for neurodegenerative and autoimmune diseases.
Switzerland GEM
GENFIT Logo
Biopharma firm developing therapies & diagnostics for rare and severe liver diseases.
France GNFT
GENFLOW BIOSCIENCES PLC Logo
Developing gene therapies to target the aging process in humans and dogs.
United Kingdom GENF

Talk to a Data Expert

Have a question? We'll get back to you promptly.